We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Genetic Testing Unravels Unusual Patterns for Fragile-X Syndrome

By LabMedica International staff writers
Posted on 11 Dec 2017
Print article
Image: Karyotyping of patient with Klinefelter syndrome, a chromosomal condition that affects male physical and cognitive development. Its signs and symptoms vary among affected individuals. This male has an extra X chromosome (Photo courtesy of Wellcome Trust).
Image: Karyotyping of patient with Klinefelter syndrome, a chromosomal condition that affects male physical and cognitive development. Its signs and symptoms vary among affected individuals. This male has an extra X chromosome (Photo courtesy of Wellcome Trust).
Fragile-X syndrome is an X-linked disorder with a prevalence of about 1 in 3,600 to 4,000 in males and 1 in 4,000 to 6,000 in females and is the main cause of inherited intellectual disability (ID) and cognitive impairment.

Fragile-X syndrome (FXS) is a rare disease and ID is frequently associated with chromosomal imbalances that often involve the X chromosome, and most clinicians primarily request molecular diagnosis of FXS for patients affected by any type of ID or developmental delay.

Scientists at the University of Naples Federico II (Naples, Italy) and their colleagues studied three women affected by intellectual/psychomotor delay and primary or secondary amenorrhea, and six men affected by mental retardation or psychomotor delay. The enrollees underwent FXS molecular diagnosis and resulted to have normal CGG triplets in the Fragile X Mental Retardation 1 (FMR1) gene, but showed atypical X chromosome patterns. Further diagnostic investigations and, in two females, array-comparative genomic hybridization (array-CGH) revealed the possible genetic cause of their conditions.

The team extracted DNA from 10 mL of whole blood samples from each subject and the CGG repeat number of FMR1 alleles up to 160 CGG repeats was determined by capillary gel electrophoresis of fluorescent-labeled DNA amplicons using primers F (labeled with NED fluorochrome) and C. The triplet repeat primed polymerase chain reaction (TP-PCR) and the Southern blot analysis of genomic DNA digested with restriction enzymes were performed. The X-inactivation analysis was carried out with the PCR-based method for methylation-dependent amplification of the polymorphic triplet repeats at the human androgen receptor (HUMARA) gene. Amplification products were separated by capillary gel electrophoresis on the ABI Prism 3130 genetic analyzer.

The investigators reported that six men affected by ID and three women affected by ID and fragile X-associated premature ovarian failure/ primary ovarian insufficiency (POF/POI) underwent FXS molecular testing. They had normal FMR1 CGG repeats, but atypical X chromosome patterns. Further investigations revealed that the six males had Klinefelter syndrome (XXY), one female was a Turner mosaic (X0/XX) and two women had novel rearrangements involving X chromosome.

The authors concluded that diagnostic investigation of atypical patterns at FMR1 locus can address patients and/or their relatives to further verify the condition by performing karyotyping and/or array-CGH. They emphasize that, for all the presented patients, their diagnostic report concluded for the absence of pathological expansion in the FMR1 gene and the presence of analytical findings that were suggestive of X chromosome abnormality. The study was published online on November 21, 2017, in the journal Clinica Chimica Acta.

Related Links:
University of Naples Federico II

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.